Word

SABER

Status

Registered

Status Code

700

Status Date

Tuesday, January 9, 2024

Serial Number

97348769

Registration Number

7265836

Registration Date

Tuesday, January 9, 2024

Mark Type

4000

Filing Date

Wednesday, April 6, 2022

Published for Opposition

Tuesday, October 24, 2023

Trademark Owner History

Saber Bio SAS - Original Registrant

Classifications

9 Downloadable computer software for the analysis of microfluidic assays, biological assays, Tcell based assays, antigen detection assays, cell based assays, antibody assays; Microfluidic instruments, namely, chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators for performing microfluidics based assays, particularly biological assays, T-cell based assays, antigen detection assays, cell based assays, antibody assays, cell-cell assays, immune response assays, assays using immune cells, using blood, tumor cells, cell suspension, mammalian cell, eukaryote and procaryotes cells assays, synthetic biology assays; scientific apparatus and instruments for analyzing eukaryote and procaryotes cells, not for medical purposes, in the nature of chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators; scientific apparatus and instruments for analyzing single cells, not for medical purposes, in the nature of chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators; scientific apparatus and instruments for analyzing cells using optical components, not for medical purposes, in the nature of chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators; none of the foregoing relating to percutaneous transluminal angioplasty and/or catheters

10 Medical instruments for the purpose of detecting cancer, immune response, infectious diseases, metabolic diseases; medical devices for viewing genomes for analysis in the fields epigenomics, transcriptomics, proteomics; Cell culture apparatus for medical use, namely, cell culture reservoirs or containers; Medical apparatuses for analyzing, manipulating, or altering cells in particular human cells; none of the foregoing relating to percutaneous transluminal angioplasty and/or catheters

42 Research and development in the field of microorganisms and cells; scientific research services relating to the isolation and cultivation of human tissues and cells; research in the field of cell separation technology; scientific research services in the field of cell separation; Biological research; Clinical research in the field of oncology, biotechnology, epidemiology, immune-oncology, infectious disease epidemiology, metabolic disease, microbiology, immunology, genomics, epigenomics, transcriptomics; Biotechnological research; Medical research; Biological research; Bacteriological research; Medical research services; Biological research services; scientific testing in the field of biotechnology; Scientific research in the field of genetics and genetic engineering; none of the foregoing relating to percutaneous transluminal angioplasty and/or catheters; none of the foregoing in the field of agriculture and farming

Trademark Events

Jan 9, 2024

Notice Of Registration Confirmation Emailed

Jan 9, 2024

Registered-Principal Register

Oct 24, 2023

Official Gazette Publication Confirmation E-Mailed

Oct 24, 2023

Published For Opposition

Oct 4, 2023

Notification Of Notice Of Publication E-Mailed

Sep 18, 2023

Electronic Record Review Complete

Sep 15, 2023

On Hold - Electronic Record Review Required

Sep 8, 2023

Approved For Pub - Principal Register

Aug 29, 2023

Teas/Email Correspondence Entered

Aug 28, 2023

Correspondence Received In Law Office

Aug 28, 2023

Teas Request For Reconsideration Received

Jun 13, 2023

Notification Of Final Refusal Emailed

Jun 13, 2023

Final Refusal E-Mailed

Jun 13, 2023

Final Refusal Written

May 5, 2023

Teas/Email Correspondence Entered

May 4, 2023

Correspondence Received In Law Office

May 4, 2023

Teas Response To Office Action Received

Feb 8, 2023

Notification Of Non-Final Action E-Mailed

Feb 8, 2023

Non-Final Action E-Mailed

Feb 8, 2023

Non-Final Action Written

Jan 24, 2023

Assigned To Examiner

Nov 17, 2022

Teas Amendment Entered Before Attorney Assigned

Nov 17, 2022

Teas Voluntary Amendment Received

Apr 11, 2022

New Application Office Supplied Data Entered

Apr 9, 2022

New Application Entered